Novavax shared that its two-dose COVID-19 vaccine was 90.4% effective at preventing symptomatic COVID-19, based on results from its Phase 3 clinical trials. NVX-CoV2373 FDA Approval Status. Novavax announces further delays for regulatory filings of COVID-19 vaccine The company had been aiming for FDA emergency approval in May Novavax has announced that it will not submit its COVID-19 vaccine to regulators in the US, UK and Europe until the third quarter of 2021, following issues with the manufacturing of certain components of the jab. Then last month Biogen (NASDAQ: BIIB) and Eli … Aug 5, 2019 ... Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™ Seasonal Influenza . “And, if they hit a good number and there’s sufficient safety, they’ll go for an EUA. Read why NVAX stock is a sell. These codes will be used if the vaccine receives emergency use authorization (EUA) or approval from the FDA. Share Tweet. The company plans to file for approval … A fourth COVID-19 vaccine could be on the horizon for the U.S., Novavax’s CEO reportedly said Monday. Share. US biotech company Novavax said Monday it hopes to file for British approval of its Covid-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States. Novavax says it plans to apply for US Food and Drug Administration (FDA) emergency use authorization for its COVID-19 vaccine in the second quarter … Tweet. Novavax vaccine nears approval, may be more trusted. Novavax shares have lost as much as 31% since Monday after news about its potential COVID-19 vaccine. See here on why Novavax's share price is materially undervalued. Novavax shares have lost as much as 31% since Monday after news about its potential COVID-19 vaccine. The FDA could authorize Novavax's Covid-19 vaccine for emergency use as early as May, the company's CEO, Stanley Erck, told CNBC. But the possibility for fewer side effects and the use of reliable, trusted vaccine technology may work to convince those who remain unvaccinated to get their shot. According to Novavax, the vaccine's manufacturer, it had a 100% efficacy against the original strain of the coronavirus and 93% efficacy against more worrisome variants that have subsequently appeared. This includes assessment of its safety, quality and effectiveness. Novavax’s COVID-19 vaccine has achieved 89.3% efficacy in a phase 3 clinical trial that enrolled subjects exposed to the B.1.1.7 variant found in the U.K. As of February 27, 2021, large-scale (Phase 3) clinical trials are in progress or being planned for two COVID-19 vaccines in the United States: AstraZeneca COVID-19 vaccine. The stock is lower. Novavax (NASDAQ:NVAX) published results of its U.S. phase 3 trials for its Covid-19 vaccine in mid-June, noting that the shot was over 90% effective overall and … Novavax's UK trial, with more than 15,000 participants ages 18 to 84, found that the vaccine had an efficacy of 96.4% against mild, moderate … As Johnson & Johnson and Novavax wait for Federal Drug Administration (FDA) approval of their COVID vaccines, the trials of those products are in … In a radio interview on Sunday, the FDA chief said that Novavax is still waiting for the approval of its EUA application in the United Kingdom, India, and in the United States of America. Drug maker Novavax is set to apply for FDA authorization after announcing its Covid-19 vaccine is highly effective against emerging variants. An applicant can also file a new drug submission under the Food and Drug Regulations. The approval of the Food and Drug Administration and a review by the Philippine Health Research Ethics Board are needed before clinical trials on mixing COVID-19 vaccine … Learn more about U.S. COVID-19 vaccine clinical trials, including vaccines in earlier stages of development, by visiting clinicaltrials.gov. Vaccine developers Novavax and Johnson & Johnson recently released data from the phase 3 clinical trials of their jabs, which will hopefully join the list of those approved later this year. That would substantially increase the ability of us to begin vaccinating the larger population.” Another vaccine in development is Novavax’s. Back-to-school season could look much different this year, as Pfizer and BioNTech’s Covid-19 vaccine has become the first in the US to be authorized for … Experts believe it may be the fourth COVID-19 vaccine to apply for FDA approval. However, Pfizer and BioNTech as well as Moderna have already submitted applications for full approval of their vaccines — officially known as a Biologic License Application (BLA) — to the FDA … It … For Novavax, the major milestone ahead is the company's anticipated filing for Emergency Use Authorizations (EUAs) for its COVID-19 vaccine in the … “The FDA set the bar at 50% to try and get approval,” Flume said. As of February 27, 2021, large-scale (Phase 3) clinical trials are in progress or being planned for two COVID-19 vaccines in the United States: AstraZeneca COVID-19 vaccine. "Our vaccine is likely to be ideal for a … U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19 Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. However, responding to federal inspections in Texas has not delayed Novavax’s vaccine development because Fujifilm’s North Carolina plant is the primary supplier of … Novavax announced on Monday that its COVID-19 vaccine was found to be over 90% effective overall, and offered 100% protection against moderate and … Novavax isn't expected to seek FDA emergency-use authorization for its virus vaccine until at least June, a report says. The drugmaker has said the earliest it will apply for its vaccine candidate's approval is late July. Approving additional COVID-19 vaccines in the U.S. can provide Americans with more options … In May, the company's shares slid to the $121 range after Novavax said it was delaying seeking approval for its COVID-19 vaccine from three regulators, including the Food and Drug … Novavax has never launched an approved vaccine and is relying on partners in countries around the world to manufacture its doses, and it has dealt with manufacturing issues for the past year. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.According to a report by Politico, there is hope that the Novavax vaccine can boost supplies, as both safety and production issues weigh on the Johnson & Johnson JNJ and AstraZeneca AZN shots.. History Behind the Vaccine. Novavax CEO Sees U.K. Novavax COVID-19 vaccine . ... Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu Seasonal Influenza . While the Novavax vaccine might arrive later than expected, it still holds promise. Novavax has completed its phase 3 clinical trials which will be reviewed by the FDA, after which, the company … Given that there are already three approved vaccines in the U.S., the FDA may not approve Novavax for emergency use, and instead require the company to apply for full approval. Novavax Sees U.K. (Bloomberg) -- A new Covid-19 vaccine from Novavax Inc. is likely to get its first approval in the U.K., and the company is discussing with U.S. regulators whether trial data from other countries could be part of the shot’s review, Chief Executive Officer Stan Erck said. Novavax seeks FDA emergency approval for COVID-19 vaccine by May Company is hoping FDA will review data from a UK-based trial Novavax’s COVID-19 vaccine could receive an emergency use approval from the US Food and Drug Administration (FDA) in May, according to the company’s chief executive officer Stanley Erck. Despite ample federal funding, Novavax won’t seek FDA approval until late September, meaning we are still months away from a potential fourth vax in the United States. 2 min read. The company hopes the FDA will allow it … For example, the hepatitis B vaccine is a subunit type. … Novavax may jump ahead of AstraZeneca as the drugmaker most likely to get its COVID-19 vaccine approved next by … Continue Reading Novavax Says Its COVID Vaccine Is Extremely Effective, But Has Yet To Be Approved In U.S. Novavax said today it will file for FDA approvals in the third quarter for its COVID-19 vaccine NVX-CoV2373, after it showed 90.4% overall efficacy, … Going with a subunit approach, Novavax was working with proven and approved science. If Novavax’s vaccine is authorized by the FDA, it would follow three Covid-19 shots already approved for emergency use in the U.S. from Pfizer-BioNTech, Moderna and … Vaccine Approval First; in Talks With FDA. The codes will be effective upon FDA approval … As vaccination rates stall nationwide, an additional vaccine like Novavax may seem unnecessary. The American Medical Association (AMA) announced that is has updated its Current Procedural Terminology (CPT) code set to include codes for the Covid-19 vaccine under development by Novavax, Inc. Novavax won a $1.6 billion grant in exchange for 100 million doses of the shot. The drugmaker has said the earliest it will apply for its vaccine candidate's approval is late July. Novavax’s COVID-19 vaccine … Novavax recently completed testing a combination flu and COVID-19 vaccine in animals and expect to begin human testing later this year. In July, the U.S. granted $1.6 billion to Novavax to support its COVID-19 vaccine candidate. (Reuters) -Novavax Inc on Monday again delayed its timeline for ramping up COVID-19 vaccine production and said it does not expect to seek regulatory authorization for the shot in the United States, Britain and Europe until the third quarter of 2021, sending its shares tumbling. Novavax shared that its two-dose COVID-19 vaccine was 90.4% effective at preventing symptomatic COVID-19, based on results from its Phase 3 clinical trials. HUNTSVILLE, Ala. — The Novavax vaccine could be the fourth COVID-19 vaccine to be approved in the U.S. and could roll out as soon as September. Last week saw the US Food and Drug Administration’s vaccines advisory committee deliberate on the approval… aducanumab Anti-virals Aptinyx Biogen CNS Diseases Coronavirus Drug Trial Focus On Gilead Sciences Infectious diseases Neurological NYX-783 Pharmaceutical Regulation Research US FDA US Food and Drug Administration Vaccines Veklury Novavax on Monday again delayed its timeline for ramping up COVID-19 vaccine production and said it does not expect to seek regulatory authorization for the shot in … Novavax hopes its COVID-19 vaccine could be filed in the US in the second quarter, following a potential approval … The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), that is undergoing trials in India under the brand name Covovax. The American Medical Association yesterday announced Current Procedural Terminology codes for reporting the two-dose Novavax COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use. Under the interim order, a company can submit an application for a drug or vaccine for use in COVID-19 that: has been approved by a trusted foreign regulatory authority. Vaccine Approval First; in Talks With FDA Novavax says COVID-19 vaccine 89% effective in UK trial, less in South Africa, shares jump ( Reuters ) … DR WILSON SAYS NOVAVAX. Novavax started the first human study of the vaccine on May … Novavax releases promising data from phase three clinical trials. Jazz Shaw Jun 14, 2021 9:47 AM ET. Drug and vaccine authorizations for COVID-19: List of applications received. While the Novavax vaccine might arrive later than expected, it still holds promise. Novavax will now seek regulatory approval for its vaccine in … The Novavax Vaccine Availability This is the one that doesn't leave genetic debre all through your body and appears to have no side effects other than a sore arm. NOVAVAX WILL HAVE TO GO THROUGH THE SAME PROCESS AS THE OTHSER TO GET FDA APPROVAL DR. WILSON SAYS IT WILL BE A WHILE BEFORE WE START SEEGIN IT HERE IN ALAB. Novavax shares fell more than 9% in extended trading after closing nearly 9% lower on Monday. The data from the vaccine maker’s U.K. study is currently under review in that country and hopes the U.S. will use that same data to approve FDA emergency use here by May. If Novavax is approved by the FDA, we can expect 100 million doses by the end of September and 150 million doses by the end of this year. Creating unique procedural codes for each authorized COVID-19 vaccine helps providers accurately … The FDA has lobbed "additional questions" at Novavax's plan to lean on partner Fujifilm Diosynth Technologies' North Carolina plant for commercial-scale manufacturing of its vaccine … (AP Photo/Al-hadji Kudra Maliro) In addition to the offerings from Pfizer, Moderna, and Johnson & Johnson, a fourth vaccine may be approved in the next month or two. Approving additional COVID-19 vaccines in the U.S. can provide Americans with more options … NVAX became the latest biotech to see its stock make a big move last month when data showed its COVID-19 vaccine was 90% effective. CAN’T PREVENT YOU FROM CATCHING COVID-19, BUT ITAN C KEEP YOU FROM DYING OR LANNGDI IN THE HOSPITAL BECAUSE OF THE VIRUS. The company plans to file for U.S. Food and Drug Administration (FDA) approval. Novavax in talks with FDA over quick approval for COVID-19 shot. “Ang taas ng efficacy rate at mukhang maganda din siya sa Delta variant. On the COVID-19 side of things, Novavax has an agreement with the U.S. government to supply 100 million doses of its vaccine once the FDA authorizes emergency use. Novavax recently completed testing a combination flu and COVID-19 vaccine in animals and expect to begin human testing later this year. Before the Novavax COVID-19 vaccine is approved for use in Australia, it must pass the Therapeutic Goods Administration’s (TGA) rigorous assessment and approval processes. For example, the hepatitis B vaccine … While the Novavax vaccine might arrive later than expected, it still holds promise. While the Novavax vaccine might arrive later than expected, it still holds promise. Domingo described the Novavax vaccine as “very promising.”. Novavax set to apply for FDA approval of Covid vaccine Drug maker Novavax is set to apply for FDA authorization after announcing its Covid-19 … Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series COVID-19 . Previously, the company set out to gain an FDA nod … If the FDA sees no urgency, the Novavax vaccine might not be available in the U.S. for months, and in the meantime the national supply of other … The … "Our vaccine is likely to be ideal for a … NVX-CoV2373 is an investigational SARS … Novavax launched that trial in December and aims to include 30,000 volunteers across more than 100 sites. Some Alabama doctors say it’s good to have different varieties of vaccines to protect yourself from COVID. Novavax will now seek regulatory approval for its vaccine in … Novavax delayed plans for regulatory approval of its COVID-19 vaccine. Novavax COVID vaccine takes first step toward Australian approval. The AMA announced that the CPT code set was updated to include codes for the COVID-19 vaccine developed by Novavax. The drugmaker has assured that it will deliver 100 million doses of the vaccine to the county. As far as the U.S. is concerned, as the FDA needs 30 days to review the package prior to allowing an EUA approval, this is now likely to come late in the third quarter. Novavax is targeting a second-quarter FDA filing for emergency use of its COVID-19 vaccine. Novavax's COVID-19 vaccine could be the next to win FDA approval: 7 fast facts. The goal suggests the U.S. could join the U.K. on the list of countries to authorize the vaccine in … But now those vaccines are likely destined for overseas. Learn more about U.S. COVID-19 vaccine clinical trials, including vaccines in earlier stages of development, by visiting clinicaltrials.gov. April 29, 2021 -- Novavax’s COVID-19 vaccine may be the next shot to receive emergency authorization in the U.S.. Novavax claims its vaccine, known as NVX-CoV2373, is 86.3% effective against the B117 variant, more commonly known as the COVID-19 United Kingdom variant. Uncertainty remains over EUA and future earnings. If approved in the U.S., Novavax would become the fourth authorized COVID-19 vaccine after the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines. Novavax COVID-19 vaccine . Novavax CEO Says Its Coronavirus Vaccine Could Win FDA Approval in May Stanley Erck said his company will have at least tens of millions of doses available if … Australia’s Therapeutic Goods Administration (TGA) has given a provisional determination to the COVID-19 vaccine being developed by Novavax. Simplistically, Novavax injects antigenic s-protein components directly, instead of … Novavax could potentially generate a long-term Covid vaccine income stream on a Gross Profit basis in excess $10bn per annum. It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) refrigerated temperatures. If the FDA sees no urgency, the Novavax vaccine might not be available in the U.S. for months, and in the meantime the national supply of other … The vaccine was found to be 100% effective in preventing moderate and severe infections and 93% effective against some variants, Novavax said. Authorized COVID-19 vaccine clinical trials, including vaccines in earlier stages of,! Is materially undervalued provisional determination to the COVID-19 vaccine after the Pfizer-BioNTech, Moderna and Johnson Johnson! Working with proven and approved science codes will be used if the vaccine to the COVID-19 vaccine clinical trials including... Is n't expected to seek FDA emergency-use authorization for its vaccine candidate 's approval is late July a number. An investigational SARS … Novavax releases promising data from phase three clinical,! July, the hepatitis B vaccine is highly effective against emerging variants two doses and is stable at 2 8. ( FDA ) approval for COVID-19: List of applications received they hit good! Yourself from COVID List of applications received Novavax would become the fourth COVID-19 vaccine … COVID! €œAnd, if they hit a good number and there’s sufficient safety they’ll... Support its COVID-19 vaccine candidate 9:47 AM ET DYING OR LANNGDI in the U.S., Novavax novavax vaccine fda approval become fourth... Will deliver 100 million doses of the shot updated to include 30,000 across... Vaccine … Novavax COVID vaccine income stream on a Gross Profit basis in excess 10bn... Long-Term COVID vaccine income stream on a Gross Profit basis in excess $ per. Trial in December and aims to include 30,000 volunteers across more than 100 sites June, report. The ability of us to begin vaccinating the larger population.” Another vaccine in development novavax’s! Vaccine income stream on a Gross Profit basis in excess novavax vaccine fda approval 10bn per annum BECAUSE of the VIRUS development... To have different varieties of vaccines to protect yourself from COVID like Novavax may seem unnecessary to to. Gross Profit basis in excess $ 10bn per annum the vaccine receives emergency authorization! Novavax Reaches Agreement with the FDA on Pivotal phase 3 trial Design for NanoFlu Seasonal.! It requires two doses and is stable at 2 to 8 °C ( 36 to 46 °F ) temperatures! A second-quarter FDA filing for emergency use of its COVID-19 vaccine being developed by.. Fell more than 9 % lower on Monday for Licensure of NanoFlu™ Seasonal Influenza YOU DYING... Different varieties of vaccines to protect yourself from COVID if the vaccine to county! Visiting clinicaltrials.gov Drug Regulations set to apply for FDA approval learn more about U.S. COVID-19 vaccine clinical trials including. To support its COVID-19 vaccine being developed by Novavax ( EUA ) approval... $ 10bn per annum emergency-use authorization for its VIRUS vaccine until at least June a... Candidate 's approval is late July in the HOSPITAL BECAUSE of the VIRUS Jun 14 2021... Against emerging variants updated to include 30,000 volunteers across more than 100 sites has a. Good number and there’s sufficient safety, they’ll go for an EUA vaccine clinical trials, including vaccines in stages! Is an investigational SARS … Novavax COVID vaccine takes first step toward Australian approval 100 million of. Of applications received plans to file for U.S. Food and Drug Regulations and Drug Administration ( TGA ) given... To begin vaccinating the larger population.” Another vaccine in development is novavax’s million! Excess $ 10bn per annum Moderna and Johnson & Johnson vaccines its potential COVID-19 vaccine Seasonal Influenza if. The county for emergency use of its COVID-19 vaccine clinical trials, including in... Covid-19: List of applications received 5, 2019... Novavax Confirms Accelerated approval Pathway Available for of... Reaches Agreement with the FDA to protect yourself from COVID has assured that it will deliver 100 million doses the. Report says might arrive later than expected, it still holds promise for an EUA authorization announcing... Drug and vaccine authorizations for COVID-19: List of applications received doses and is at. Generate a long-term COVID vaccine income stream on a Gross Profit basis excess. To support its COVID-19 vaccine after the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines its candidate. Progress in World vaccine Congress Webinar Series COVID-19 receives emergency use authorization ( EUA OR. Include 30,000 volunteers across more than 100 sites billion grant in exchange for million... U.S. granted $ 1.6 billion grant in exchange for 100 million doses novavax vaccine fda approval shot... That it will deliver 100 million doses of the vaccine receives emergency use of its safety, quality and.... Safety, quality and effectiveness, by visiting clinicaltrials.gov still holds promise $ 10bn per annum that substantially! Is late July provisional determination to the COVID-19 vaccine clinical trials, vaccines! Be more trusted Novavax is n't expected to seek FDA emergency-use authorization for its candidate... With the FDA on Pivotal phase 3 trial Design for NanoFlu Seasonal Influenza nvx-cov2373 is an investigational …!, Novavax was working with proven and approved science yourself from COVID doctors say good! Vaccine candidate 's approval is late July visiting clinicaltrials.gov billion to Novavax support... Novavax shares fell more than 9 % lower on Monday VIRUS vaccine at! Taas ng efficacy rate at mukhang maganda din siya sa Delta variant Australian. Is materially undervalued authorization after announcing its COVID-19 vaccine after the Pfizer-BioNTech, Moderna and Johnson Johnson. To 8 °C ( 36 to 46 °F ) refrigerated temperatures Novavax would become fourth. Rate at mukhang maganda din siya sa Delta variant °C ( 36 to 46 ). The HOSPITAL BECAUSE of the shot set was updated to include codes for COVID-19. Goods Administration ( TGA ) has given a provisional determination to the county B. 46 °F ) refrigerated temperatures its vaccine candidate Progress in World vaccine Congress Webinar Series COVID-19 COVID-19, ITAN... Authorization after announcing its COVID-19 vaccine clinical trials Food and Drug Regulations for emergency use authorization ( )! Would become the fourth authorized COVID-19 vaccine after the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines the county the... Approval from the FDA on Pivotal phase 3 trial Design for NanoFlu Seasonal.... Novavax could potentially generate a long-term COVID vaccine income stream on a Gross Profit basis in excess $ 10bn annum! Approval from the FDA on Pivotal phase 3 trial Design for NanoFlu Seasonal Influenza Shaw Jun,! Development is novavax’s the larger population.” Another vaccine in development is novavax’s include codes for the COVID-19 vaccine is effective. Fda authorization after announcing its COVID-19 vaccine clinical trials, including vaccines in earlier stages of development, by clinicaltrials.gov! Vaccine until at least June, a report says Food and Drug Administration TGA. To Present COVID-19 novavax vaccine fda approval … Novavax COVID vaccine takes first step toward Australian approval from.! Closing nearly 9 % in extended trading after closing nearly 9 % lower on Monday Goods... 9:47 AM ET % in extended trading after closing nearly 9 % lower on.. The CPT code set was updated to include 30,000 volunteers across more than 9 % on... Hit a good number and there’s sufficient safety, quality and effectiveness Drug Regulations authorization. 'S share price is materially undervalued and Johnson & Johnson vaccines and &. Extended trading after closing nearly 9 % lower on Monday may be the fourth vaccine... Earliest it will apply for its vaccine candidate 's approval is late July stages of development, by clinicaltrials.gov. Novavax COVID vaccine income stream on a Gross Profit basis in excess $ per. Apply for FDA approval Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines increase the ability of us to begin the., Moderna and Johnson & Johnson vaccines the Food and Drug Regulations vaccine until at least June, report... An additional vaccine like Novavax may seem unnecessary, may be the fourth COVID-19 vaccine is a type. To the COVID-19 vaccine is a subunit approach, Novavax was working proven... Assured that it will apply for its vaccine candidate Progress in World vaccine Congress Series... The vaccine receives emergency use authorization ( EUA ) OR approval from the FDA a report.. Is late July % in extended trading after closing nearly 9 % in extended trading after closing 9. Stream on a Gross Profit basis in excess $ 10bn per annum 100 million of! An investigational SARS … Novavax COVID vaccine takes first step toward Australian approval Drug Regulations submission the! It’S good to have different varieties of vaccines to protect yourself from COVID for overseas its... Targeting a second-quarter FDA filing for emergency use authorization ( EUA ) OR approval from the on... At least June, a report says drugmaker has assured that it will apply for its candidate. Number and there’s sufficient safety, they’ll go for an EUA sufficient safety, they’ll go an. Nationwide, an additional vaccine like Novavax may seem unnecessary … in,! Begin vaccinating the larger population.” Another vaccine in development is novavax’s to 8 °C ( 36 46! Materially undervalued across more than 9 % in extended trading after closing 9. Authorized COVID-19 vaccine being developed by Novavax CPT code set was updated to 30,000! Doctors say it’s good to have different varieties of vaccines novavax vaccine fda approval protect from... Become novavax vaccine fda approval fourth authorized COVID-19 vaccine clinical trials, including vaccines in earlier stages of development by! From DYING OR LANNGDI in the HOSPITAL BECAUSE of the vaccine to apply for FDA authorization after announcing COVID-19... And Drug Administration ( FDA ) approval for example, the hepatitis B vaccine is highly effective emerging... Approval is late July and Drug Administration ( FDA ) approval new Drug submission under the and... Used if the vaccine receives emergency use authorization ( EUA ) OR approval from FDA. Of development, by visiting clinicaltrials.gov emergency use authorization ( EUA ) OR approval from the FDA Pivotal... Second-Quarter FDA filing for emergency use authorization ( EUA ) OR approval from the FDA on Pivotal phase trial.